Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A hypoxia-related prognostic model predicts overall survival and treatment response in hepatocellular carcinoma. | Biosci Rep | 2022 | 36314455 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma. | Pathol Oncol Res | 2022 | 36313898 | PubTator, text mining | PubMed |
| Advances in immunotherapy for glioblastoma multiforme. | Front Immunol | 2022 | 36311781 | PubTator, text mining | PubMed |
| Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b. | iScience | 2022 | 36310646 | PubTator, text mining | PubMed |
| Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors. | Front Pharmacol | 2022 | 36299893 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Outer Membrane Vesicles: An Emerging Vaccine Platform. | Vaccines (Basel) | 2022 | 36298443 | PubTator, text mining | PubMed |
| Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201. | Cancers (Basel) | 2022 | 36291783 | PubTator, text mining | PubMed |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. | Front Immunol | 2022 | 36275733 | PubTator, text mining | PubMed |
| The prognostic impact of the immune signature in head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36268020 | PubTator, text mining | PubMed |
| Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC. | Front Immunol | 2022 | 36263048 | PubTator, text mining | PubMed |
| Targeting Endocytosis and Cell Communications in the Tumor Immune Microenvironment. | Cell Commun Signal | 2022 | 36258231 | PubTator, text mining | PubMed |
| Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. | J Immunother Cancer | 2022 | 36252996 | PubTator, text mining | PubMed |
| Site-to-site cross-talk in OST-B glycosylation of hCEACAM1-IgV. | Proc Natl Acad Sci U S A | 2022 | 36251991 | PubTator, text mining | PubMed |
Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases. | Contrast Media Mol Imaging | 2022 | 36247849 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
| Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy. | Cancers (Basel) | 2022 | 36230676 | PubTator, text mining | PubMed |
| Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis. | Dis Markers | 2022 | 36212177 | PubTator, text mining | PubMed |
| Nanomaterials based on thermosensitive polymer in biomedical field. | Front Chem | 2022 | 36212064 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=32